VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
PINCPremier, Inc.
$28.26$2.3B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksPINCP/E History

PINC logoPremier, Inc. (PINC) P/E Ratio History

Expensive

Trading at 128.5x vs 5Y avg 20.2x · 100th percentile · Material premium to history · Data 2015–2025

Current P/E (TTM)
128.5x
+537% vs 5Y avg
5Y Avg P/E
20.2x
Median 17.5x
5Y Percentile
100th
Upper end of range
PEG Ratio
N/A
5-Year P/E Range
128.5x
Min8.0xMedian17.5xMax70.7x
TTM EPS$-0.29
Price$28.26
Earnings Yield0.78%
EPS Growth (1Y)-78.8%
EPS Growth (5Y)-35.9%

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, Premier, Inc. (PINC) trades at a price-to-earnings ratio of 128.5x, with a stock price of $28.26 and trailing twelve-month earnings per share of $-0.29.

The current P/E is 537% above its 5-year average of 20.2x. Over the past five years, PINC's P/E has ranged from a low of 8.0x to a high of 70.7x, placing the current valuation at the 100th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, PINC trades at a 481% premium to its sector peers. The sector includes 234 companies with P/E ratios ranging from 0.0x to 197.0x.

Relative to the broader market, PINC commands a significant premium over the S&P 500 median P/E of 24.4x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our PINC DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

PINC Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
128.5vs22.1
+481%
Above Sector
vs. S&P 500
128.5vs24.4
+425%
Above Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -79% EPS growth (1Y)

PINC P/E vs Peers

Healthcare Communications, Workforce and Supply Chain peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
HSIC logoHSICHenry Schein, Inc.
$9B24.47.75+7%
MCK logoMCKMcKesson Corporation
$90B19.6-+49%
INVA logoINVAInnoviva, Inc.
$2B6.80.66+817%Best
HCA logoHCAHCA Healthcare, Inc.
$84B13.20.63+29%
THC logoTHCTenet Healthcare Corporation
$15B11.10.34Best-53%
CYH logoCYHCommunity Health Systems, Inc.
$426M0.8Lowest-+197%
UHS logoUHSUniversal Health Services, Inc.
$9B6.10.38+37%
ENSG logoENSGThe Ensign Group, Inc.
$9B26.31.91+14%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

PINC Historical P/E Data (2015–2025)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2025 Q4Jun 30 2025$21.93$0.3170.7x+291%
FY2025 Q3Mar 31 2025$19.28$0.5634.4x+90%
FY2025 Q2-$21.20$0.9522.3x+23%
FY2025 Q1Sep 30 2024$20.00$2.518.0x-56%
FY2024 Q4Jun 30 2024$18.67$2.188.6x-53%
FY2024 Q3Mar 31 2024$22.10$1.8012.3x-32%
FY2024 Q2Dec 31 2023$22.36$1.4915.0x-17%
FY2024 Q1Sep 30 2023$21.50$1.4814.5x-20%
FY2023 Q4Jun 30 2023$27.66$1.4718.8x+4%
FY2023 Q3Mar 31 2023$32.37$1.5421.0x+16%
FY2023 Q2Dec 31 2022$34.98$1.4723.8x+32%
FY2023 Q1Sep 30 2022$33.94$1.5521.9x+21%
FY2022 Q4-$35.68$2.1616.5x-9%
FY2022 Q3-$35.59$2.3115.4x-15%
FY2022 Q2Dec 31 2021$41.17$2.3817.3x-4%
FY2022 Q1-$38.76$2.1218.3x+1%
FY2021 Q4Jun 30 2021$34.79$2.5713.5x-25%
FY2021 Q3Mar 31 2021$33.85$1.8618.2x+1%
FY2021 Q2-$35.10$2.0117.5x-3%
FY2017 Q3Mar 31 2017$31.83$2.1314.9x-17%
FY2017 Q2Dec 31 2016$30.36$5.555.5x-70%
FY2017 Q1Sep 30 2016$32.34$2.7411.8x-35%
FY2016 Q4-$32.70$2.7212.0x-34%
FY2015 Q2Dec 31 2014$33.53$18.271.8x-90%

Average P/E for displayed period: 18.1x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

11+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

PINC — Frequently Asked Questions

Quick answers to the most common questions about buying PINC stock.

What is PINC's P/E ratio?

Premier, Inc. (PINC) trailing twelve-month P/E ratio is 128.5x, based on TTM diluted EPS of $-0.29. The 5-year average P/E is 20.2x and the historical range spans 8.0x to 70.7x.

Is PINC stock overvalued or undervalued?

PINC trades at 128.5x P/E, above its 5-year average of 20.2x. The 100th percentile ranking within the 8.0x–70.7x historical range indicates a premium to historical valuation.

Is PINC stock expensive?

Yes, PINC is expensive relative to its own history. The current P/E of 128.5x is above the 5-year average of 20.2x and also above the Healthcare sector median of 22.1x. The stock sits at the 100th percentile of its 5-year valuation range.

What is PINC's historical P/E range?

Over the past 5 years, PINC's P/E ratio has ranged from 8.0x to 70.7x, with a median of 17.5x and an average of 20.2x. The current P/E of 128.5x places the stock at the 100th percentile of this range. Full historical data spans 2015–2025.

How does PINC's P/E compare to the S&P 500?

PINC trades at 128.5x P/E versus the S&P 500 median of 24.4x. The 427% premium to the market typically reflects higher expected earnings growth or quality.

How does PINC's valuation compare to Healthcare peers?

Premier, Inc. P/E of 128.5x compares to the Healthcare sector median of 22.1x. The premium reflects expected growth above peers or stronger fundamentals. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is PINC's PEG ratio?

PINC PEG ratio is N/A, based on a P/E of 128.5x and EPS growth of -78.8%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is PINC's earnings yield?

PINC earnings yield is 0.78%, the inverse of its 128.5x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

PINC P/E Ratio History (2015–2025)

Quarterly valuation multiple from closing price and trailing EPS

Current70.7x
Period Avg20.2x
Range8.0x - 70.7x
Change+373%
20 quartersMar 31, 2017 - Jun 30, 2025